Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Unaudited) - USD ($)	Total	January 2023 PIPE	Arena purchase agreement	Series A Convertible Preferred Stock	Convertible Preferred Stock	Common Stock	Common Stock January 2023 PIPE	Common Stock Arena purchase agreement	Additional Paid-in Capital	Additional Paid-in Capital January 2023 PIPE	Additional Paid-in Capital Arena purchase agreement	Accumulated Deficit
Beginning Balance at Dec. 31, 2021					$ 20,857,453
Beginning Balance, Shares at Dec. 31, 2021					13,802,758
Beginning Balance at Dec. 31, 2021	$ (14,686,247)					$ 31			$ 2,213,547			$ (16,899,825)
Beginning Balance, Shares at Dec. 31, 2021						308,443
Issuance of common stock upon exercise of stock options	429,430					$ 74			429,356
Common stock exercised						735,859
Stock-based compensation expense	42,556								42,556
Net loss	(2,879,395)											(2,879,395)
Ending Balance at Mar. 31, 2022					$ 20,857,453
Ending Balance, Shares at Mar. 31, 2022					13,802,758
Ending Balance at Mar. 31, 2022	(17,093,656)					$ 105			2,685,459			(19,779,220)
Ending Balance, Shares at Mar. 31, 2022						1,044,302
Beginning Balance at Dec. 31, 2021					$ 20,857,453
Beginning Balance, Shares at Dec. 31, 2021					13,802,758
Beginning Balance at Dec. 31, 2021	(14,686,247)					$ 31			2,213,547			(16,899,825)
Beginning Balance, Shares at Dec. 31, 2021						308,443
Net loss	(11,964,663)
Ending Balance at Jun. 30, 2022				$ 4,345,022
Ending Balance, Shares at Jun. 30, 2022				4,305
Ending Balance at Jun. 30, 2022	(1,792,079)					$ 1,594			27,070,815			(28,864,488)
Ending Balance, Shares at Jun. 30, 2022						15,937,185
Beginning Balance at Mar. 31, 2022					$ 20,857,453
Beginning Balance, Shares at Mar. 31, 2022					13,802,758
Beginning Balance at Mar. 31, 2022	(17,093,656)					$ 105			2,685,459			(19,779,220)
Beginning Balance, Shares at Mar. 31, 2022						1,044,302
Issuance of common stock upon exercise of stock options, net of shares withheld to settle tax withholding requirements	230,071					$ 68			230,003
Issuance of common stock upon exercise of stock options, net of shares withheld to settle tax withholding requirements, Shares						679,265
Conversion of convertible preferred stock, Temporary equity values					$ (20,857,453)
Conversion of convertible preferred stock, Temporary equity shares					(13,802,758)
Conversion of convertible preferred stock, Value	20,857,453					$ 1,064			20,856,389
Conversion of convertible preferred stock, Shares						10,643,403
Issuance of common stock in connection with the Transaction and Maxim Private Placement, net of redemptions, net tangible assets, and issuance costs, Value	3,443,750					$ 357			3,443,393
Issuance of common stock in connection with the Transaction and Maxim Private Placement, net of redemptions, net tangible assets, and issuance costs, Shares						3,570,215
Issuance of convertible preferred stock, net of issuance costs				$ 4,143,854
Issuance of convertible preferred stock, net of issuance costs, Shares				4,305
Accretion of convertible preferred stock to redemption value				$ 201,168
Accretion of convertible preferred stock to redemption value	(201,168)								(201,168)
Stock-based compensation expense	56,739								56,739
Net loss	(9,085,268)											(9,085,268)
Ending Balance at Jun. 30, 2022				$ 4,345,022
Ending Balance, Shares at Jun. 30, 2022				4,305
Ending Balance at Jun. 30, 2022	(1,792,079)					$ 1,594			27,070,815			(28,864,488)
Ending Balance, Shares at Jun. 30, 2022						15,937,185
Beginning Balance at Dec. 31, 2022				$ 4,517,710
Beginning Balance, Shares at Dec. 31, 2022				4,305
Beginning Balance at Dec. 31, 2022	(6,247,088)					$ 1,671			28,655,164			(34,903,923)
Beginning Balance, Shares at Dec. 31, 2022						16,709,221
Issuance of common stock		$ 3,200,449	$ 49,158				$ 240	$ 4		$ 3,200,209	$ 49,154
Issuance of common stock, shares							2,406,242	37,230
Accretion of convertible preferred stock to redemption value				$ 86,816
Accretion of convertible preferred stock to redemption value	(86,816)								(86,816)
Stock-based compensation expense	300,765								300,765
Net loss	(2,481,312)											(2,481,312)
Ending Balance at Mar. 31, 2023				$ 4,604,526
Ending Balance, Shares at Mar. 31, 2023				4,305
Ending Balance at Mar. 31, 2023	(5,264,844)					$ 1,915			32,118,476			(37,385,235)
Ending Balance, Shares at Mar. 31, 2023						19,152,693
Beginning Balance at Dec. 31, 2022				$ 4,517,710
Beginning Balance, Shares at Dec. 31, 2022				4,305
Beginning Balance at Dec. 31, 2022	$ (6,247,088)					$ 1,671			28,655,164			(34,903,923)
Beginning Balance, Shares at Dec. 31, 2022						16,709,221
Common stock exercised	2,445
Net loss	$ (3,892,932)
Ending Balance at Jun. 30, 2023				$ 4,690,398
Ending Balance, Shares at Jun. 30, 2023				4,305
Ending Balance at Jun. 30, 2023	(6,350,362)					$ 1,915			32,444,578			(38,796,855)
Ending Balance, Shares at Jun. 30, 2023						19,155,138
Beginning Balance at Mar. 31, 2023				$ 4,604,526
Beginning Balance, Shares at Mar. 31, 2023				4,305
Beginning Balance at Mar. 31, 2023	(5,264,844)					$ 1,915			32,118,476			(37,385,235)
Beginning Balance, Shares at Mar. 31, 2023						19,152,693
Issuance of common stock upon exercise of stock options	1,443								1,443
Common stock exercised						2,445
Accretion of convertible preferred stock to redemption value				$ 85,872
Accretion of convertible preferred stock to redemption value	(85,872)								(85,872)
Conversion of Private Warrants to Public Warrants	131,562								131,562
Stock-based compensation expense	278,969								278,969
Net loss	(1,411,620)											(1,411,620)
Ending Balance at Jun. 30, 2023				$ 4,690,398
Ending Balance, Shares at Jun. 30, 2023				4,305
Ending Balance at Jun. 30, 2023	$ (6,350,362)					$ 1,915			$ 32,444,578			$ (38,796,855)
Ending Balance, Shares at Jun. 30, 2023						19,155,138